European Healthtech startup funding raised during Q1 2024.
In Q1 2024, 124 European Healthtech companies raised a combined €1.0B across 124 funding rounds, down 40.9% versus Q1 2023. UK led by capital raised, and The Future of Health Grant (FoHG) program was the most active investor. Data as of 9 Jul 2026.
10 exits · €437M disclosed.
| Calypso Biotech | Acquisition | Jan 2024 | €425M |
| Apotea | Acquisition | Jan 2024 | €12M |
| €40M |
| Phagenesis | Series D+ | Mar 2024 | €39M |
| Relation Therapeutics | Seed | Mar 2024 | €32M |
| Enterprise Therapeutics | Series B | Jan 2024 | €30M |
| Aqemia | Series A | Jan 2024 | €30M |
| Onera Health | Series C | Jan 2024 | €30M |
| Protembis | Series B | Mar 2024 | €30M |
| Hilo (Aktiia) | Other | Feb 2024 | €28M |
| icotec | Growth/Late | Jan 2024 | €28M |
| LEM Surgical | Series B | Jan 2024 | €24M |
| Spineart | Debt | Mar 2024 | €21M |
| Kinvent | Other | Jan 2024 | €16M |
